From: Real-world costs of autosomal dominant polycystic kidney disease in the Nordics
Patient characteristic | CKD 1–3 (n = 64) | CKD 4–5 (n = 55) | Dialysis (n = 61) | Transplant (n = 63) | P value |
---|---|---|---|---|---|
Country, n (%)a | <0.0001 | ||||
Denmark | 26 (41) | 32 (58) | 32 (52) | 28 (44) | |
Sweden | 19 (30) | 12 (22) | 14 (23) | 13 (21) | |
Norway | 19 (30) | 11 (20) | 4 (7) | 16 (25) | |
Finland | 0 (0) | 0 (0) | 11 (18) | 6 (10) | |
Sex (female), n (%) | 38 (59) | 29 (53) | 33 (54) | 31 (49) | 0.7144 |
Age (years), mean ± SDb | 52 ± 13 | 57 ± 12 | 64 ± 10 | 59 ± 10 | <0.0001 |
BMI (≥30 kg/m2), n (%) | 10 (16) | 11 (20) | 15 (25) | 14 (22) | 0.7667 |
Currently employed, n (%) | 40 (63) | 27 (49) | 13 (21) | 28 (44) | <0.0001 |
Currently employed (aged <65 years), n (%) | 40 (78) | 27 (64) | 12 (38) | 26 (59) | <0.0001 |
Comorbidities (≥1), n (%) | 43 (67) | 44 (80) | 61 (100) | 45 (76) | <0.0001 |
Dialysis in the past 12 months, n (%) a | . | . | 61 (100) | 5 (8) | <0.0001 |
Haemodialysis | . | . | 51 (84) | 5 (100) | 1.0000 |
Peritoneal dialysis | . | . | 12 (20) | 0 (0) | 0.5754 |